Moyom Biotech
PrivateLast Round
Early Funding
Sep 28, 2026
Est. Valuation
$69.5M
Total Funding Raised
$85.9M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Moyom Biotech operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was an Early Funding round in September 2026.
Moyom Biotech is a biotechnology company that specializes in the research, development, and production of regenerative aesthetic biomaterials and absorbable Class III medical implants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Moyom Biotech Comparables
Compare Moyom Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imeik Technology Development Co., Ltd. | 81% | |
| Huadong Medicine Co., Ltd. | 81% | |
| Daewoong Pharmaceutical | 79% |
For institutional investors. Book with your work email.
Moyom Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 28, 2026 | ||||
| Series C | Aug 8, 2025 | ||||
| Series B Extension | Nov 15, 2024 | ||||
| Series A | Sep 29, 2021 | ||||
| Angel | Jul 11, 2018 |
For institutional investors. Book with your work email.
Moyom Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Early Funding |
| Boyuan Capital | Series B Extension |
| Jinding Capital | Series B Extension, Angel |
| Hengxu Capital | Series B Extension, Series A |
| Huagai Capital | Series C |
| BlueRun Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2026
$41M raised, led by Cathay Capital.
- Aug 8, 2025
Raised $28M with BlueRun Ventures and Huagai Capital.
For institutional investors. Book with your work email.
Moyom Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Moyom Biotech's valuation, stock price, and market status.
Is Moyom Biotech a public or private company?
Moyom Biotech is a private company.
What is the current stock price of Moyom Biotech?
Moyom Biotech is a private company, so its shares have no public market price. Caplight tracks Moyom Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Moyom Biotech worth (valuation)?
Moyom Biotech's valuation is estimated at $69.5M based on funding round data.
Can I buy Moyom Biotech stock?
Moyom Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Moyom Biotech's last funding round?
Moyom Biotech's most recent funding round was Early Funding on September 28, 2026.
Who are the main investors in Moyom Biotech?
Key investors in Moyom Biotech include Cathay Capital, Boyuan Capital, Hengxu Capital.
Will Moyom Biotech IPO soon?
No public IPO plans have been announced for Moyom Biotech.
How can I track Moyom Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Moyom Biotech's shares on secondary markets.